Here are three things to know about the agreement:
- Sasmar acquired all stock to the privately held biotech in exchange for an upfront payment of an undisclosed cash amount.
- Sasmar first partnered with Aquatrove in 2008 by commercializing the biotech’s patented fertility lubricant.
- The deal closed this week, officially transferring ownership of Aquatrove’s global portfolio of intellectual property, patents, and 14 years of research data to Sasmar.
More articles on supply chain:
Opioid overdose drug now offered over the counter at 96 Krogers in Kentucky
Study finds AstraZeneca’s FluMist vaccine effective, contradicts CDC
Are physicians and medical device reps too buddy-buddy?
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
